Home » Author Archive
Harvard Bioscience (NASDAQ:HBIO) Getting Somewhat Favorable News Coverage, Study Shows
News stories about Harvard Bioscience (NASDAQ:HBIO) have been trending somewhat positive on Saturday, Accern Sentiment Analysis reports. Accern identifies positive and negative media coverage by monitoring more than twenty million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Harvard Bioscience earned a media sentiment score of 0.03 on Accern’s scale. Accern also assigned press coverage about the medical instruments supplier...
Edward James Kernaghan Purchases 6,300 Shares of Black Diamond Group (BDI) Stock
Black Diamond Group (TSE:BDI) insider Edward James Kernaghan acquired 6,300 shares of the firm’s stock in a transaction that occurred on Friday, March 9th. The stock was purchased at an average cost of C$2.46 per share, with a total value of C$15,498.00.
Edward James Kernaghan also recently made the following trade(s):
On Friday, April 6th, Edward James Kernaghan bought 9,900 shares of Black Diamond Group stock. The stock was bought at an average price of C$2.38 per share, with a total value of C$23,562.00.
On Wednesday, April 4th, Edward...
Harry Fisch Purchases 10,000 Shares of Female Health (NASDAQ:VERU) Stock
-logo.jpg&h=100&w=100&zc=1){kind=logo}
Female Health (NASDAQ:VERU) Director Harry Fisch bought 10,000 shares of the business’s stock in a transaction on Monday, March 12th. The stock was purchased at an average cost of $1.80 per share, with a total value of $18,000.00. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink.
Harry Fisch also recently made the following trade(s):
On Friday, March 16th, Harry Fisch bought 5,000 shares of Female Health stock. The stock was purchased at an average cost of $1.96 per share, with a total value...
Tartisan Resources Corp (TTC) Director D. Mark Appleby Purchases 135,000 Shares
Tartisan Resources Corp (CNSX:TTC) Director D. Mark Appleby acquired 135,000 shares of Tartisan Resources stock in a transaction on Tuesday, March 6th. The stock was purchased at an average cost of $0.14 per share, for a total transaction of $18,900.00.
CNSX:TTC opened at $0.16 on Friday. Tartisan Resources Corp has a 1 year low of $0.07 and a 1 year high of $0.19.
COPYRIGHT VIOLATION WARNING: “[[title]]” was originally published by [[site]] and is the property of of [[site]]. If you are viewing this piece of content on another website,...
Aclaris Therapeutics (NASDAQ:ACRS) Given Buy Rating at Cantor Fitzgerald
Aclaris Therapeutics (NASDAQ:ACRS)‘s stock had its “buy” rating restated by stock analysts at Cantor Fitzgerald in a report issued on Monday, March 12th. They currently have a $50.00 price target on the biotechnology company’s stock. Cantor Fitzgerald’s target price would suggest a potential upside of 203.77% from the stock’s current price.
The analysts wrote, “Takeways from the quarter that support our positive thesis: 1) Approval of Eskata for SK in mid-December, 2) A productive R&D Day on 10/4/17,...
Cass Information Systems (NASDAQ:CASS) vs. Its Peers Head-To-Head Analysis
Cass Information Systems (NASDAQ: CASS) is one of 120 public companies in the “Business services, not elsewhere classified” industry, but how does it contrast to its competitors? We will compare Cass Information Systems to similar companies based on the strength of its risk, profitability, valuation, dividends, analyst recommendations, earnings and institutional ownership.
Volatility & Risk
Cass Information Systems has a beta of 1.19, indicating that its stock price is 19% more volatile than the S&P 500. Comparatively, Cass...
Head-To-Head Review: Pampa Energia (PAM) versus Dominion Energy (D)
Dominion Energy (NYSE: D) and Pampa Energia (NYSE:PAM) are both utilities companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, institutional ownership, dividends, earnings, profitability, analyst recommendations and risk.
Risk & Volatility
Dominion Energy has a beta of 0.27, suggesting that its share price is 73% less volatile than the S&P 500. Comparatively, Pampa Energia has a beta of 1.13, suggesting that its share price is 13% more volatile than the S&P 500....
Gonzalez David Angulo Buys 14,790 Shares of Scynexis (SCYX) Stock
Scynexis (NASDAQ:SCYX) insider Gonzalez David Angulo bought 14,790 shares of the business’s stock in a transaction dated Thursday, March 8th. The shares were acquired at an average cost of $1.69 per share, for a total transaction of $24,995.10. Following the purchase, the insider now owns 88,790 shares of the company’s stock, valued at approximately $150,055.10. The purchase was disclosed in a filing with the SEC, which can be accessed through this link.
Gonzalez David Angulo also recently made the following trade(s):
On Thursday,...
Halyard Health (HYH) Getting Somewhat Positive News Coverage, Accern Reports
News stories about Halyard Health (NYSE:HYH) have trended somewhat positive this week, Accern reports. The research firm identifies negative and positive press coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Halyard Health earned a news impact score of 0.17 on Accern’s scale. Accern also gave news articles about the medical instruments supplier an impact score of 45.7752394187241 out of 100, meaning that recent press...
Core Gold (CGLD) Insider Robert Washer Sells 90,000 Shares
Core Gold (CVE:CGLD) insider Robert Washer sold 90,000 shares of the business’s stock in a transaction that occurred on Thursday, March 8th. The stock was sold at an average price of C$0.34, for a total value of C$30,600.00.
Robert Washer also recently made the following trade(s):
On Friday, April 6th, Robert Washer sold 2,500 shares of Core Gold stock. The shares were sold at an average price of C$0.29, for a total value of C$725.00.
On Tuesday, April 3rd, Robert Washer sold 7,500 shares of Core Gold stock. The shares were sold at an...
Somewhat Critical News Coverage Somewhat Unlikely to Impact Dicks Sporting Goods (DKS) Stock Price
News articles about Dicks Sporting Goods (NYSE:DKS) have been trending somewhat negative this week, Accern Sentiment Analysis reports. The research group rates the sentiment of press coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Dicks Sporting Goods earned a media sentiment score of -0.13 on Accern’s scale. Accern also assigned headlines about the sporting goods retailer...
Timothy Archer Sells 6,465 Shares of Lam Research Co. (LRCX) Stock
Lam Research Co. (NASDAQ:LRCX) insider Timothy Archer sold 6,465 shares of the business’s stock in a transaction dated Friday, March 9th. The shares were sold at an average price of $214.28, for a total transaction of $1,385,320.20. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink.
Timothy Archer also recently made the following trade(s):
On Wednesday, March 21st, Timothy Archer sold 16,574 shares of Lam Research stock. The stock was sold at an average price of $221.41, for a total transaction...
Analyzing Marathon Petroleum (MPC) & Western Gas Partners (WES)
Marathon Petroleum (NYSE: MPC) and Western Gas Partners (NYSE:WES) are both oils/energy companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, profitability, valuation, risk, dividends, analyst recommendations and institutional ownership.
Volatility and Risk
Marathon Petroleum has a beta of 1.34, meaning that its share price is 34% more volatile than the S&P 500. Comparatively, Western Gas Partners has a beta of 1.13, meaning that its share price is 13% more volatile than the...
Somewhat Positive News Coverage Somewhat Unlikely to Impact Coupa (NASDAQ:COUP) Stock Price
Media stories about Coupa (NASDAQ:COUP) have been trending somewhat positive on Saturday, Accern Sentiment reports. The research firm ranks the sentiment of media coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Coupa earned a media sentiment score of 0.09 on Accern’s scale. Accern also assigned news headlines about the technology company an impact score of 45.9204503029583 out of...
IES (IESC) & Its Rivals Financial Comparison
IES (NASDAQ: IESC) is one of 4 publicly-traded companies in the “Electrical work” industry, but how does it weigh in compared to its peers? We will compare IES to related businesses based on the strength of its dividends, valuation, institutional ownership, analyst recommendations, profitability, risk and earnings.
Institutional and Insider Ownership
78.4% of IES shares are owned by institutional investors. Comparatively, 88.9% of shares of all “Electrical work” companies are owned by institutional investors. 60.0% of IES...
Biogen (NASDAQ:BIIB) Receives Buy Rating from Credit Suisse Group
Biogen (NASDAQ:BIIB)‘s stock had its “buy” rating reaffirmed by research analysts at Credit Suisse Group in a research note issued to investors on Monday, March 12th. They currently have a $384.00 target price on the biotechnology company’s stock. Credit Suisse Group’s price target indicates a potential upside of 49.04% from the company’s current price.
BIIB has been the topic of a number of other research reports. Royal Bank of Canada restated a “hold” rating and set a $321.00 price target on shares...
Antares Pharma (ATRS) Releases Quarterly Earnings Results, Beats Estimates By $0.01 EPS
Antares Pharma (NASDAQ:ATRS) released its earnings results on Tuesday, March 13th. The specialty pharmaceutical company reported ($0.02) EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.03) by $0.01, Morningstar.com reports. Antares Pharma had a negative net margin of 30.71% and a negative return on equity of 44.29%. The firm had revenue of $14.00 million during the quarter, compared to analysts’ expectations of $15.44 million. Antares Pharma’s revenue was down 1.4% compared to the same quarter last year....
Verastem (VSTM) Receiving Somewhat Positive News Coverage, Report Finds
Press coverage about Verastem (NASDAQ:VSTM) has been trending somewhat positive on Friday, Accern Sentiment reports. Accern scores the sentiment of news coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Verastem earned a daily sentiment score of 0.09 on Accern’s scale. Accern also assigned news headlines about the biopharmaceutical company an impact score of 46.263277085806...
Corporate Capital Trust Inc (CCT) Director Acquires $80,000.00 in Stock
Corporate Capital Trust Inc (NYSE:CCT) Director Frederick Arnold bought 5,000 shares of the company’s stock in a transaction on Thursday, March 8th. The shares were bought at an average cost of $16.00 per share, for a total transaction of $80,000.00. The acquisition was disclosed in a filing with the SEC, which is accessible through this hyperlink.
NYSE:CCT traded down $0.03 during trading hours on Friday, hitting $17.20. 564,773 shares of the company were exchanged, compared to its average volume of 707,531. Corporate Capital Trust Inc has...
GCP Applied Technologies Inc (NYSE:GCP) Director Danny R. Shepherd Purchases 2,388 Shares
GCP Applied Technologies Inc (NYSE:GCP) Director Danny R. Shepherd bought 2,388 shares of the stock in a transaction that occurred on Monday, March 12th. The stock was bought at an average cost of $31.35 per share, for a total transaction of $74,863.80. Following the transaction, the director now owns 12,768 shares of the company’s stock, valued at approximately $400,276.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.
NYSE GCP traded down $0.70...
John Patrick Casey Sells 4,133 Shares of General Dynamics Co. (GD) Stock
General Dynamics Co. (NYSE:GD) EVP John Patrick Casey sold 4,133 shares of the stock in a transaction dated Thursday, March 8th. The shares were sold at an average price of $225.27, for a total transaction of $931,040.91. Following the sale, the executive vice president now directly owns 96,055 shares of the company’s stock, valued at $21,638,309.85. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
John Patrick Casey also recently made the following trade(s):...
Mongodb (NASDAQ:MDB) Releases FY19 Earnings Guidance
Mongodb (NASDAQ:MDB) issued an update on its FY19 earnings guidance on Tuesday morning. The company provided EPS guidance of ($1.66-1.62) for the period, compared to the Thomson Reuters consensus EPS estimate of ($1.63). The company issued revenue guidance of $211-215 million, compared to the consensus revenue estimate of $206.58 million.Mongodb also updated its Q1 guidance to ($0.44-0.43) EPS.
NASDAQ:MDB traded down $2.23 during trading hours on Friday, reaching $40.77. The company’s stock had a trading volume of 293,434 shares, compared...
Franks International (NYSE:FI) Lifted to “Hold” at Zacks Investment Research
Franks International (NYSE:FI) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research note issued to investors on Monday, March 12th.
According to Zacks, “Frank’s International N.V. is a provider of engineered tubular services to the oil and gas industry. Its tubular services include the handling and installation of multiple joints of pipe to establish a cased wellbore; and the installation of smaller diameter pipe inside a cased wellbore to provide a conduit for produced...
Steelcase (SCS) Getting Somewhat Positive News Coverage, Report Finds
News stories about Steelcase (NYSE:SCS) have trended somewhat positive on Friday, according to Accern Sentiment. Accern identifies positive and negative press coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Steelcase earned a coverage optimism score of 0.06 on Accern’s scale. Accern also gave press coverage about the business services provider an impact score of 46.8876724182929...
HFF (NYSE:HF) Getting Somewhat Positive News Coverage, Analysis Finds
News stories about HFF (NYSE:HF) have trended somewhat positive on Friday, according to Accern Sentiment. Accern identifies positive and negative press coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. HFF earned a coverage optimism score of 0.11 on Accern’s scale. Accern also gave press coverage about the financial services provider an impact score of 46.0330238777654 out of 100,...
Perficient, Inc. (NASDAQ:PRFT) Chairman Sells $1,038,004.83 in Stock
Perficient, Inc. (NASDAQ:PRFT) Chairman Jeffrey S. Davis sold 43,413 shares of Perficient stock in a transaction dated Monday, March 12th. The stock was sold at an average price of $23.91, for a total value of $1,038,004.83. The sale was disclosed in a filing with the SEC, which can be accessed through this link.
Jeffrey S. Davis also recently made the following trade(s):
On Thursday, March 8th, Jeffrey S. Davis sold 4,649 shares of Perficient stock. The stock was sold at an average price of $23.88, for a total value of $111,018.12.
NASDAQ:PRFT...
United Continental (NYSE:UAL) Updates FY18 Earnings Guidance
United Continental (NYSE:UAL) updated its FY18 earnings guidance on Tuesday. The company provided EPS guidance of $6.50-8.50 for the period, compared to the Thomson Reuters consensus EPS estimate of $7.53.
A number of research firms recently weighed in on UAL. Morgan Stanley set a $80.00 price objective on shares of United Continental and gave the stock a hold rating in a research note on Friday. Stephens set a $76.00 price objective on shares of United Continental and gave the stock a hold rating in a research note on Thursday, March 29th. Zacks...
The Trade Desk (TTD) Earns Daily News Sentiment Rating of 0.17
Media coverage about The Trade Desk (NASDAQ:TTD) has trended somewhat positive on Friday, according to Accern Sentiment Analysis. The research firm scores the sentiment of news coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. The Trade Desk earned a news sentiment score of 0.17 on Accern’s scale. Accern also gave news headlines about the technology company an impact score of 44.7423737781947...
Carlyle Group (NASDAQ:CG) Stock Rating Upgraded by Citigroup
Carlyle Group (NASDAQ:CG) was upgraded by equities research analysts at Citigroup from a “neutral” rating to a “buy” rating in a research note issued on Monday, March 12th, MarketBeat reports. The brokerage currently has a $28.50 price objective on the financial services provider’s stock. Citigroup’s price target indicates a potential upside of 40.74% from the stock’s current price.
CG has been the topic of several other research reports. BidaskClub upgraded Carlyle Group from a “hold” rating...
BlueLinx (NYSE:BXC) Given Media Impact Rating of 0.25
News articles about BlueLinx (NYSE:BXC) have been trending positive this week, Accern reports. Accern ranks the sentiment of news coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. BlueLinx earned a media sentiment score of 0.25 on Accern’s scale. Accern also assigned news coverage about the construction company an impact score of 45.5865539745687 out of 100, meaning that recent news coverage is somewhat...
L3 Technologies (LLL) Cut to Hold at Zacks Investment Research
L3 Technologies (NYSE:LLL) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report released on Monday, March 12th.
According to Zacks, “L3 Technologies enjoys a leading position in defense electronics, communications and ISR markets. Moreover, its consistent growth in the commercial aviation space, especially in North America and Europe, is appreciable. The company also follows a disciplined divestment strategy to efficiently focus on its core operations. In addition to its strong...
Oaktree Capital Group LLC (NYSE:OAK) Major Shareholder Acquires $213,048.00 in Stock
Oaktree Capital Group LLC (NYSE:OAK) major shareholder Oaktree Capital Management Lp bought 26,900 shares of Oaktree Capital Group stock in a transaction dated Thursday, March 8th. The shares were bought at an average cost of $7.92 per share, with a total value of $213,048.00. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Major shareholders that own at least 10% of a company’s stock are required to disclose their sales and purchases with the SEC.
Oaktree Capital...
Head-To-Head Analysis: IES (NASDAQ:IESC) and The Competition
IES (NASDAQ: IESC) is one of 4 publicly-traded companies in the “Electrical work” industry, but how does it compare to its competitors? We will compare IES to related companies based on the strength of its risk, dividends, analyst recommendations, earnings, institutional ownership, profitability and valuation.
Earnings and Valuation
This table compares IES and its competitors top-line revenue, earnings per share and valuation.
Gross Revenue
Net Income
Price/Earnings Ratio
IES
$810.70 million
$13.42 million
N/A
IES Competitors
$4.94...
Spectrum Pharmaceuticals (NASDAQ:SPPI) Earning Somewhat Favorable News Coverage, Analysis Finds
Media headlines about Spectrum Pharmaceuticals (NASDAQ:SPPI) have trended somewhat positive this week, Accern Sentiment Analysis reports. The research firm rates the sentiment of press coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Spectrum Pharmaceuticals earned a news impact score of 0.15 on Accern’s scale. Accern also assigned headlines about the biotechnology company an impact score of 47.5628257205665...
Foot Locker (FL) Receives New Coverage from Analysts at Credit Suisse Group
Investment analysts at Credit Suisse Group initiated coverage on shares of Foot Locker (NYSE:FL) in a research note issued to investors on Monday, March 12th, MarketBeat.com reports. The firm set an “outperform” rating and a $50.00 price target on the athletic footwear retailer’s stock. Credit Suisse Group’s target price indicates a potential upside of 7.62% from the stock’s current price.
FL has been the topic of a number of other research reports. Deutsche Bank raised Foot Locker from a “hold” rating to...
Sallie Mae (SLM) Lowered to Hold at Zacks Investment Research
Sallie Mae (NASDAQ:SLM) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued to investors on Monday, March 12th.
According to Zacks, “Shares of Sallie Mae have underperformed the industry over the past six months. Also, the company doesn’t have an impressive earnings surprise history. It surpassed the Zacks Consensus Estimate for earnings in one of the trailing four quarters. A competitive business environment and consistently increasing expenses remain...
Everest Re Group (NYSE:RE) Upgraded to Strong-Buy by Zacks Investment Research
Zacks Investment Research upgraded shares of Everest Re Group (NYSE:RE) from a hold rating to a strong-buy rating in a report released on Monday, March 12th. They currently have $302.00 price objective on the insurance provider’s stock.
According to Zacks, “Everest Re has substantially benefited from its global presence, product diversification, capital adequacy, financial flexibility and traditional risk management capabilities. Strategic endeavors to ramp up growth pave way for long-term improvement. It is divesting underperforming...
Somewhat Positive Media Coverage Somewhat Unlikely to Affect LRR Energy (NYSE:LRE) Share Price
News articles about LRR Energy (NYSE:LRE) have been trending somewhat positive recently, according to Accern Sentiment Analysis. The research firm ranks the sentiment of press coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. LRR Energy earned a media sentiment score of 0.08 on Accern’s scale. Accern also assigned headlines about the oil and gas producer an impact score of 45.1642038265638...
Positive Press Coverage Somewhat Unlikely to Affect Enduro Royalty Trust (NDRO) Stock Price
News articles about Enduro Royalty Trust (NYSE:NDRO) have been trending positive recently, according to Accern Sentiment Analysis. The research firm ranks the sentiment of press coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Enduro Royalty Trust earned a media sentiment score of 0.34 on Accern’s scale. Accern also assigned headlines about the oil and gas producer an impact...
Houston Wire & Cable (HWCC) Receiving Somewhat Favorable Press Coverage, Analysis Finds
News articles about Houston Wire & Cable (NASDAQ:HWCC) have been trending somewhat positive recently, according to Accern Sentiment Analysis. The research firm ranks the sentiment of press coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Houston Wire & Cable earned a media sentiment score of 0.06 on Accern’s scale. Accern also assigned headlines about the industrial...
CoreSite (COR) Stock Rating Upgraded by UBS
UBS upgraded shares of CoreSite (NYSE:COR) from a market perform rating to an outperform rating in a report released on Monday, March 12th, The Fly reports.
Several other research firms have also recently weighed in on COR. Citigroup cut their price target on shares of CoreSite from $115.00 to $105.00 and set a neutral rating on the stock in a report on Friday, February 9th. Jefferies Group reiterated a buy rating on shares of CoreSite in a research note on Thursday, February 8th. KeyCorp upgraded shares of CoreSite from a sector weight rating...
American Superconductor (AMSC) Receives Daily Media Sentiment Score of 0.17
News articles about American Superconductor (NASDAQ:AMSC) have been trending somewhat positive recently, according to Accern Sentiment Analysis. The research firm ranks the sentiment of press coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. American Superconductor earned a media sentiment score of 0.17 on Accern’s scale. Accern also assigned headlines about the technology company...
Somewhat Positive Press Coverage Somewhat Likely to Affect New Age Beverages (NBEV) Stock Price
News articles about New Age Beverages (NASDAQ:NBEV) have been trending somewhat positive recently, according to Accern Sentiment Analysis. The research firm ranks the sentiment of press coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. New Age Beverages earned a media sentiment score of 0.13 on Accern’s scale. Accern also assigned headlines about the company an impact score...
Old Line Bancshares, Inc. (OLBK) Director Buys $162,850.00 in Stock
-logo.png&h=100&w=100&zc=1){kind=logo}
Old Line Bancshares, Inc. (NASDAQ:OLBK) Director Carla Hargrove Mcgill bought 5,000 shares of the company’s stock in a transaction that occurred on Monday, March 5th. The stock was purchased at an average cost of $32.57 per share, with a total value of $162,850.00. Following the acquisition, the director now directly owns 22,123 shares in the company, valued at approximately $720,546.11. The acquisition was disclosed in a filing with the SEC, which is accessible through this link.
Shares of OLBK traded down $0.50 during midday trading on...
Voyager Therapeutics (NASDAQ:VYGR) Rating Reiterated by Piper Jaffray
Piper Jaffray reiterated their buy rating on shares of Voyager Therapeutics (NASDAQ:VYGR) in a report issued on Monday, March 12th. Piper Jaffray currently has a $40.00 price objective on the stock.
VYGR has been the topic of a number of other research reports. Zacks Investment Research lowered shares of Voyager Therapeutics from a hold rating to a sell rating in a research note on Thursday, January 25th. Morgan Stanley started coverage on shares of Voyager Therapeutics in a research note on Friday, February 2nd. They set an overweight rating on...
Merck & Co., Inc. (MRK) Upgraded to Outperform by Leerink Swann
Leerink Swann upgraded shares of Merck & Co., Inc. (NYSE:MRK) from a market perform rating to an outperform rating in a report published on Monday, March 12th, MarketBeat reports.
A number of other equities analysts also recently commented on MRK. Sanford C. Bernstein reaffirmed a buy rating and set a $64.00 target price on shares of Merck & Co., Inc. in a research note on Wednesday, November 15th. Deutsche Bank reduced their target price on shares of Merck & Co., Inc. from $62.00 to $59.00 and set a hold rating on the stock in a...
Intec Pharma’s (NASDAQ:NTEC) Buy Rating Reiterated at HC Wainwright
Intec Pharma (NASDAQ:NTEC)‘s stock had its “buy” rating restated by equities researchers at HC Wainwright in a research report issued on Monday, March 12th. They presently have a $16.00 target price on the biotechnology company’s stock. HC Wainwright’s price objective points to a potential upside of 153.97% from the company’s previous close.
A number of other equities analysts also recently commented on NTEC. Oppenheimer set a $15.00 target price on shares of Intec Pharma and gave the stock a “buy”...
Insider Selling: First Defiance Financial Corp. (FDEF) Insider Sells 2,193 Shares of Stock
First Defiance Financial Corp. (NASDAQ:FDEF) insider Gregory R. Allen sold 2,193 shares of First Defiance Financial stock in a transaction dated Friday, March 9th. The shares were sold at an average price of $56.56, for a total value of $124,036.08. The sale was disclosed in a filing with the SEC, which is available at this hyperlink.
NASDAQ:FDEF traded down $0.66 during mid-day trading on Friday, reaching $56.99. The stock had a trading volume of 24,931 shares, compared to its average volume of 31,329. The company has a market capitalization of...
Sunesis Pharmaceuticals (NASDAQ:SNSS) Given Coverage Optimism Rating of 0.09
News stories about Sunesis Pharmaceuticals (NASDAQ:SNSS) have been trending somewhat positive on Friday, Accern reports. The research group identifies negative and positive press coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Sunesis Pharmaceuticals earned a news impact score of 0.09 on Accern’s scale. Accern also assigned headlines about the biopharmaceutical company...
Capricor Therapeutics (CAPR) Rating Increased to Buy at Zacks Investment Research
Zacks Investment Research upgraded shares of Capricor Therapeutics (NASDAQ:CAPR) from a hold rating to a buy rating in a research report released on Monday, March 12th. Zacks Investment Research currently has $2.00 price target on the biotechnology company’s stock.
According to Zacks, “Capricor Therapeutics, Inc. is a biotechnology company. It is focused on the development of novel therapeutics to prevent and treat heart disease. The Company has two drug candidates in development: Cenderitide and CU-NP. Capricor Therapeutics, Inc.,...
